THE UK STEM CELL FOUNDATION

Trosolwg o'r elusen
Gweithgareddau - sut mae'r elusen yn gwario ei harian
The Key aim of the charity is to address the funding gap that hinders the translation of stem cell research into new treatments that have the potential for direct clinical benefit. The charity supports Universities, medical schools and hospitals in the United Kingdom for the benefit of the general public/mankind.
Incwm a gwariant
Data ar gyfer y flwyddyn ariannol yn gorffen 31 December 2023
Pobl

3 Ymddiriedolwyr
Gweithwyr sydd â chyfanswm buddion dros £60,000
Nid oes gan unrhyw weithwyr gyfanswm buddion dros £60,000Codi arian
Masnachu
Taliadau i ymddiriedolwyr
Beth, pwy, sut, ble
- Addysg/hyfforddiant
- Hybu Iechyd Neu’r Achub O Fywydau
- Y Cyhoedd/dynolryw
- Rhoi Grantiau I Sefydliadau
- Darparu Eiriolaeth/cyngor/gwybodaeth
- Noddi Neu’n Gwneud Gwaith Ymchwil
- Cymru A Lloegr
Llywodraethu
- 14 Mehefin 2005: Cofrestrwyd
- PROPOSED NEW STEM CELL RESEARCH CHARITY (Enw blaenorol)
- Polisi a gweithdrefnau bwlio ac aflonyddu
- Trin cwynion
- Polisi a gweithdrefnau cwynion
- Polisi a gweithdrefnau cronfeydd arian wrth gefn
- Polisi a gweithdrefnau rheolaethau ariannol mewnol elusen
- Polisi a gweithdrefnau rheoli risg mewnol
- Polisi a gweithdrefnau buddsoddi cronfeydd elusen
- Buddsoddi
- Talu staff
- Rheoli risg
- Polisi a gweithdrefnau diogelu
- Polisi a gweithdrefnau cyfryngau cymdeithasol
- Polisi a gweithdrefnau gwrthdaro buddiannau ymddiriedolwyr
Ymddiriedolwyr
Ymddiriedolwyr yw’r bobl sy’n gyfrifol am reoli’ gwaith, rheolaeth a gweinyddiaeth yr elusen. Gellir adnabod ymddiriedolwyr wrth enwau eraill megis cyfarwyddwyr, aelodau pwyllgor, llywodraethwyr neu rywbeth arall, ac nid ydynt fel arfer wedi’u cyflogi gan yr elusen. Mae’r ymddiriedolwyr yn gyfrifol am ddiweddaru'r rhestr hon a gallant wneud hyn wrth ddiweddaru eu manylion fel y maent yn digwydd trwy'r gwasanaeth ar-lein.
3 Ymddiriedolwyr
Enw | Rôl | Dyddiad y penodiad | Ymddiriedolaethau eraill | Statws adrodd ymddiriedolaethau eraill | ||||
---|---|---|---|---|---|---|---|---|
Trevor Michael Phillips | Ymddiriedolwr | 02 January 2025 |
|
|
||||
JAMES TAYLOR | Ymddiriedolwr | 08 October 2012 |
|
|
||||
PROFESSOR TREVOR MERVYN JONES CBE | Ymddiriedolwr |
|
|
Hanes ariannol
Dyddiad diwedd cyfnod ariannol
Incwm / Gwariant | 31/12/2019 | 31/12/2020 | 31/12/2021 | 31/12/2022 | 31/12/2023 | ||
---|---|---|---|---|---|---|---|
|
Cyfanswm Incwm Gros | £643.50k | £285.25k | £52.78k | £28.37k | £122.40k | |
|
Cyfanswm gwariant | £279.87k | £344.15k | £317.67k | £320.72k | £380.27k | |
|
Incwm o gontractau'r llywodraeth | N/A | N/A | N/A | N/A | N/A | |
|
Incwm o grantiau'r llywodraeth | N/A | N/A | N/A | N/A | N/A | |
|
Incwm o roddion a chymynroddion | £638.96k | N/A | N/A | N/A | N/A | |
|
Incwm o weithgareddau masnachu eraill | £0 | N/A | N/A | N/A | N/A | |
|
Incwm - Weithgareddau elusennol | £0 | N/A | N/A | N/A | N/A | |
|
Incwm - Gwaddolion | £0 | N/A | N/A | N/A | N/A | |
|
Incwm - Buddsoddiad | £0 | N/A | N/A | N/A | N/A | |
|
Incwm - Arall | £4.55k | N/A | N/A | N/A | N/A | |
|
Incwm - Cymynroddion | £614.98k | N/A | N/A | N/A | N/A | |
|
Gwariant - Ggweithgareddau elusennol | £65.68k | N/A | N/A | N/A | N/A | |
|
Gwariant - Ar godi arian | £214.19k | N/A | N/A | N/A | N/A | |
|
Gwariant - Llywodraethu | £6.15k | N/A | N/A | N/A | N/A | |
|
Gwariant - Sefydliad grantiau | £0 | N/A | N/A | N/A | N/A | |
|
Gwariant - Rheoli buddsoddiadau | £0 | N/A | N/A | N/A | N/A | |
|
Gwariant - Arall | £0 | N/A | N/A | N/A | N/A |
Cyfrifon a datganiadau enillion blynyddol
Teitl | Blwyddyn adrodd | Dyddiad derbyn | Derbyniwyd | Download |
---|---|---|---|---|
Adroddiad blynyddol | 31 Rhagfyr 2023 | 15 Tachwedd 2024 | 15 diwrnod yn hwyr | |
Cyfrifon a TAR | 31 Rhagfyr 2023 | 15 Tachwedd 2024 | 15 diwrnod yn hwyr | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 31 Rhagfyr 2022 | 04 Hydref 2023 | Ar amser | |
Cyfrifon a TAR | 31 Rhagfyr 2022 | 04 Hydref 2023 | Ar amser | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 31 Rhagfyr 2021 | 09 Ionawr 2023 | 70 diwrnod yn hwyr | |
Cyfrifon a TAR | 31 Rhagfyr 2021 | 09 Ionawr 2023 | 70 diwrnod yn hwyr | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 31 Rhagfyr 2020 | 31 Hydref 2021 | Ar amser | |
Cyfrifon a TAR | 31 Rhagfyr 2020 | 31 Hydref 2021 | Ar amser | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 31 Rhagfyr 2019 | 07 Rhagfyr 2020 | 37 diwrnod yn hwyr | |
Cyfrifon a TAR | 31 Rhagfyr 2019 | 12 Mawrth 2021 | 132 diwrnod yn hwyr | Download Agorwch mewn ffenestr newydd |
Dogfen lywodraethu
Nid dyma destun llawn dogfen lywodraethu'r elusen.
MEMORANDUM AND ARTICLES AS AMENDED BY SPECIAL RESOLUTION(S) DATED 13/06/2005 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 21/02/2011
Gwrthrychau elusennol
3. THE CHARITABLE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE THE PRESERVATION, PROMOTION AND ADVANCEMENT OF HUMAN HEALTH AND WELFARE AND THE ADVANCEMENT AND PROMOTION OF KNOWLEDGE AND EDUCATION FOR THE BENEFIT OF THE PUBLIC BY: 3.1 ENHANCING AND PROMOTING KNOWLEDGE OF AND ENGAGING IN, FUNDING AND SUPPORTING RESEARCH INTO THE MECHANISMS OF CELL DEGENERATION, REGENERATION AND MALFUNCTION AND THEIR LINKS TO DEGENERATIVE AND OTHER DISEASES, DISABILITIES, DISORDERS AND CONDITIONS IN RESPECT OF WHICH STEM CELL RELATED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS OR TECHNOLOGIES MIGHT BE BENEFIT; 3.2 ENGAGING IN, FUNDING AND SUPPORTING RESEARCH INTO STEM CELL AND STEM CELL-BASED OR DERIVED METHODS AND TECHNOLOGIES, WITH A VIEW TO DISCOVERING, INVENTING, IMPROVING, DEVELOPING, PRODUCING AND APPLYING MEDICINE, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES, INCLUDING THE TRANSLATION OF PURE RESEARCH INTO OUTPUTS TO A STANDARD SUSCEPTIBLE OF CLINICAL TRIALS WITH A VIEW TO ESTABLISHING THE EFFICACY AND SUPPORTING THE CLINICAL DEVELOPMENT OF MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES CAPABLE OF APPLICATION; 3.3 EDUCATING AND INFORMING THE PUBLIC IN RELATION TO STEM CELLS AND THE EFFICACY OF STEM CELL BASED OR DERIVED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES; AND 3.4 PROMOTING THE ETHICAL USE OF STEM CELLS WHETHER IN RESEARCH, DEVELOPMENT OR OTHERWISE AND THE ETHICAL USE AND PRODUCTION OF STEM CELLS AND STEM CELL BASED OR DERIVED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES AND THE APPROPRIATE REGULATION AND MANAGEMENT THEREOF AND EDUCATING AND INFORMING THE PUBLIC IN RELATION TO SUCH MATTERS.
Maes buddion
NATIONAL AND OVERSEAS
Contact Information
- Cyfeiriad yr elusen:
-
3rd floor 45 Albemarle Street
London
W1S 4JL
- Ffôn:
- 02045724151
- E-bost:
- info@ukscf.org
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Diolch am eich adborth. Oes gennych 5 munud i rannu eich barn am y gwasanaeth hwn?Open in new window